North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Paritaprevir</strong> (CAS: 1216941-48-8) is a potent HCV NS3/4A protease inhibitor synthesized via advanced chiral catalysis. Its molecular formula is C<sub>27</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for Direct-Acting Antiviral (DAA) regimens.</li>
<li>Fixed-dose combination therapies targeting Hepatitis C Virus genotypes.</li>
<li>R&D of novel antiviral compounds in clinical trial phases.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store under inert atmosphere at controlled temperatures. Avoid direct contact; use appropriate PPE. Clinical use requires monitoring for drug-drug interactions and hepatic function.</p>